Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rilonacept in Coronary Artery Disease
NCT00417417Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Dec 2006
- Primary completion
- Apr 2008
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of rilonacept in coronary artery disease (CAD), sponsored by National Heart, Lung, and Blood Institute. Started Dec 2006; status: completed.
02
Drugs
rilonacept
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00417417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00417417.